Filing Overview
Clover Health Investments, Corp. filed a Form 8-K under Item 8.01, with an event date of February 4, 2021. The filing was signed on February 5, 2021. It reports a regulatory investigation following the company’s recently completed business combination.
Material Event and Regulatory Investigation
- Following publication of an article by Hindenburg Research on February 4, 2021, Clover Health received a letter from the U.S. Securities and Exchange Commission indicating that the SEC is conducting an investigation.
- The investigation relates to certain matters referenced in the Hindenburg article.
- The SEC requested document and data preservation covering the period from January 1, 2020, through the present.
- Clover Health stated that it intends to cooperate with the investigation.
Financial Information
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, guidance, or other financial metrics.
Risks, Contingencies, and Unusual Items
The SEC investigation represents a material regulatory and legal risk. The filing does not disclose the potential scope, duration, financial impact, penalties, or outcome of the investigation, nor does it identify any related accounting reserves or contingencies.
Key Facts to Verify
- Details and allegations contained in the Hindenburg Research article.
- The specific matters under SEC investigation and the company’s responses to SEC requests.
- Any subsequent SEC filings describing developments, potential liabilities, or resolution of the investigation.
- Whether the investigation affects previously reported financial statements, disclosures, or forecasts.